BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 19587242)

  • 1. Stepwise acquisition of pyrimethamine resistance in the malaria parasite.
    Lozovsky ER; Chookajorn T; Brown KM; Imwong M; Shaw PJ; Kamchonwongpaisan S; Neafsey DE; Weinreich DM; Hartl DL
    Proc Natl Acad Sci U S A; 2009 Jul; 106(29):12025-30. PubMed ID: 19587242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibility to pyrimethamine of DHFR I164L single mutant Plasmodium falciparum.
    Andriantsoanirina V; Durand R; Pradines B; Baret E; Bouchier C; Ratsimbasoa A; Ménard D
    Malar J; 2011 Sep; 10():283. PubMed ID: 21951962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel alleles of the Plasmodium falciparum dhfr highly resistant to pyrimethamine and chlorcycloguanil, but not WR99210.
    Hankins EG; Warhurst DC; Sibley CH
    Mol Biochem Parasitol; 2001 Sep; 117(1):91-102. PubMed ID: 11551635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A shared Asian origin of the triple-mutant dhfr allele in Plasmodium falciparum from sites across Africa.
    Maïga O; Djimdé AA; Hubert V; Renard E; Aubouy A; Kironde F; Nsimba B; Koram K; Doumbo OK; Le Bras J; Clain J
    J Infect Dis; 2007 Jul; 196(1):165-72. PubMed ID: 17538897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Travel and the emergence of high-level drug resistance in Plasmodium falciparum in southwest Uganda: results from a population-based study.
    Lynch CA; Pearce R; Pota H; Egwang C; Egwang T; Bhasin A; Cox J; Abeku TA; Roper C
    Malar J; 2017 Apr; 16(1):150. PubMed ID: 28415996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya.
    Iriemenam NC; Shah M; Gatei W; van Eijk AM; Ayisi J; Kariuki S; Vanden Eng J; Owino SO; Lal AA; Omosun YO; Otieno K; Desai M; ter Kuile FO; Nahlen B; Moore J; Hamel MJ; Ouma P; Slutsker L; Shi YP
    Malar J; 2012 Jul; 11():134. PubMed ID: 22540158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular epidemiology of malaria in Cameroon. XXVII. Clinical and parasitological response to sulfadoxine-pyrimethamine treatment and Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase alleles in Cameroonian children.
    Tahar R; Basco LK
    Acta Trop; 2007 Aug; 103(2):81-9. PubMed ID: 17640607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrimethamine analogs as strong inhibitors of double and quadruple mutants of dihydrofolate reductase in human malaria parasites.
    Sardarian A; Douglas KT; Read M; Sims PF; Hyde JE; Chitnumsub P; Sirawaraporn R; Sirawaraporn W
    Org Biomol Chem; 2003 Mar; 1(6):960-4. PubMed ID: 12929634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of dihydrofolate reductase gene mutations in Plasmodium falciparum parasites among pregnant women in Nigeria after reported use of sulfadoxine-pyrimethamine.
    Ojurongbe O; Nguetse CN; Fayemiwo SA; Falade CO; Ojurongbe TA; Thomas BN; Meyer CG; Velavan TP
    Pathog Glob Health; 2018 Mar; 112(2):86-92. PubMed ID: 29318942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ordered accumulation of mutations conferring resistance to sulfadoxine-pyrimethamine in the Plasmodium falciparum parasite.
    Mita T; Ohashi J; Venkatesan M; Marma AS; Nakamura M; Plowe CV; Tanabe K
    J Infect Dis; 2014 Jan; 209(1):130-9. PubMed ID: 23922363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational drug design approach for overcoming drug resistance: application to pyrimethamine resistance in malaria.
    McKie JH; Douglas KT; Chan C; Roser SA; Yates R; Read M; Hyde JE; Dascombe MJ; Yuthavong Y; Sirawaraporn W
    J Med Chem; 1998 Apr; 41(9):1367-70. PubMed ID: 9554869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic pyrimethamine-resistant plasmodium falciparum reveals transmission-blocking potency of P218, a novel antifolate candidate drug.
    Posayapisit N; Pengon J; Prommana P; Shoram M; Yuthavong Y; Uthaipibull C; Kamchonwongpaisan S; Jupatanakul N
    Int J Parasitol; 2021 Jul; 51(8):635-642. PubMed ID: 33713651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct haplotypes of dhfr and dhps among Plasmodium falciparum isolates in an area of high level of sulfadoxine-pyrimethamine (SP) resistance in eastern Sudan.
    Al-Saai S; Kheir A; Abdel-Muhsin AM; Al-Ghazali A; Nwakanma D; Swedberg G; Babiker HA
    Infect Genet Evol; 2009 Sep; 9(5):778-83. PubMed ID: 19379843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagenesis of dihydrofolate reductase from Plasmodium falciparum: analysis in Saccharomyces cerevisiae of triple mutant alleles resistant to pyrimethamine or WR99210.
    Ferlan JT; Mookherjee S; Okezie IN; Fulgence L; Sibley CH
    Mol Biochem Parasitol; 2001 Mar; 113(1):139-50. PubMed ID: 11254962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Widespread resistance mutations to sulfadoxine-pyrimethamine in malaria parasites imported to China from Central and Western Africa.
    Zhao L; Pi L; Qin Y; Lu Y; Zeng W; Xiang Z; Qin P; Chen X; Li C; Zhang Y; Wang S; Si Y; Yang G; Rosenthal BM; Huang Y; Yang Z
    Int J Parasitol Drugs Drug Resist; 2020 Apr; 12():1-6. PubMed ID: 31809965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites.
    Nzila AM; Mberu EK; Sulo J; Dayo H; Winstanley PA; Sibley CH; Watkins WM
    Antimicrob Agents Chemother; 2000 Apr; 44(4):991-6. PubMed ID: 10722502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil.
    Basco LK; Ringwald P
    Am J Trop Med Hyg; 2000 Feb; 62(2):271-6. PubMed ID: 10813484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of a dhfr mutation conferring high-level drug resistance in Plasmodium falciparum populations from southwest Uganda.
    Lynch C; Pearce R; Pota H; Cox J; Abeku TA; Rwakimari J; Naidoo I; Tibenderana J; Roper C
    J Infect Dis; 2008 Jun; 197(11):1598-604. PubMed ID: 18471065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular epidemiology of drug resistance markers of Plasmodium falciparum in Yunnan Province, China.
    Huang F; Tang L; Yang H; Zhou S; Liu H; Li J; Guo S
    Malar J; 2012 Jul; 11():243. PubMed ID: 22839209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Plasmodium falciparum parasites resistant to sulfadoxine/pyrimethamine in pregnant women in Yaoundé, Cameroon: emergence of highly resistant pfdhfr/pfdhps alleles.
    Chauvin P; Menard S; Iriart X; Nsango SE; Tchioffo MT; Abate L; Awono-Ambéné PH; Morlais I; Berry A
    J Antimicrob Chemother; 2015 Sep; 70(9):2566-71. PubMed ID: 26080363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.